Search Results
Nov 13, 2025, 08:27 ET 2026 GIVING OUTLOOK: RESILIENT DONORS DRIVE GROWTH AMID SHIFTS IN PHILANTHROPY
Joseph Mrak III, the
More news about: Foundation Source
Nov 13, 2025, 07:42 ET Domain Therapeutics Appoints Boston-Based Pharma Leader Jean-Marie Cuillerot, M.D., as Chief Medical Officer
lifecycle management of ipilimumab, the first approved immune checkpoint inhibitor for cancer. In this role, he designed and led pivotal Phase II and III clinical trials across multiple indications and supported regulatory filings in the United States and Europe. At EMD Serono, an affiliate
More news about: Domain Therapeutics
Nov 13, 2025, 07:27 ET Natural Grocers® Serves Up Thanksgiving Hot Deals, Good Food and Gratitude
without notice. Natural Grocers reserves the right to correct errors. Void where prohibited by law. [iii] Offers valid only from 10/31/25 – 11/29/25 for in-store customer purchases at participating stores and cannot be combined with other offers. Quantity
More news about: Natural Grocers by Vitamin Cottage, Inc.
Nov 13, 2025, 07:00 ET Graphite One Confirms the Presence of Rare Earth Elements at its Graphite Creek Deposit
CEO: "The presence of two Defense Production Act Title III materials – graphite and REEs – in a single deposit further underscores Graphite Creek as a generational deposit."
More news about: Graphite One Inc.
Nov 13, 2025, 07:00 ET EVERBAY CAPITAL RELEASES FOLLOW-UP LETTER TO GOLDEN ENTERTAINMENT'S BOARD OF DIRECTORS, EXPRESSING SIGNIFICANT CONCERNS ABOUT THE ANNOUNCED TRANSACTIONS
treatment from a Board which has already shown its allegiance to the interests of the CEO rather than to the interests of the broader shareholder base. (iii) The MTA includes a termination fee of $16.4mm ($0.61 per share), 25% of which is payable to Blake Sartini, if the MTA is terminated during the go-shop
More news about: Everbay Capital LP
Nov 13, 2025, 06:45 ET Neutrogena® and OGX® Leverage Decades of Skin Expertise with Latest Hair Innovations
https://theindustry.beauty/new-data-reveals-top-skincare-ingredients-of-2024/iii due to breakage when used with Hair Restore shampoo and conditioner vs non-conditioning shampoo.iv Vogue International LLC
More news about: Kenvue Inc.
Nov 13, 2025, 06:30 ET Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
to IMU-856, (ii) a $1.1 million decrease in external development costs related to the completion of the phase 2 CALLIPER trial in the prior year and (iii) a $0.2 million decrease related to costs across numerous categories. The decrease was offset by a $1.2 million increase in personnel expenses for R&D,
More news about: Immunic, Inc.
Nov 13, 2025, 05:40 ET SNPS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Synopsys, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
economics of its Design IP business; (ii) as a result, "certain road map and resource decisions" were unlikely to "yield their intended results"; and (iii) the foregoing had a material negative impact on financial results. The Synopsys investor class action further alleges
More news about: Robbins Geller Rudman & Dowd LLP
Nov 13, 2025, 01:22 ET 第8回中国国際サーカスフェスティバル、横琴・長隆で世界クラスのパフォーマンスを1週間にわたり開催
長隆は、この28年間にわたり、世界トップクラスのサーカス芸術を一堂に集めてきました。絶え間ない進化を重ねながら、同社の作品は伝統的な形式を大切に守りつつも革新を追求し、卓越性を維持しながらそれを超えることを目指し続けています。初期の「国際サーカスガラ」では、世界最高峰のサーカス演目が披露されました。その後、世界初の大型シチュエーションサーカスである「マジックレジェンド」、さらに進化した「マジックレジェンド III」、そしてスペクタクルショー部門で第31回TEA Theaアワード「優秀業績賞」を受賞した「長隆ショー」へと発展してきました。長隆は、質の高い文化・エンターテインメントプログラムへの長年の取り組みを反映した公演を通じて、年間を通じて観客を魅了し続けています。Su Zhigang会長の掲げる「最高水準のみを追求する（only
More news about: Chimelong Group
Nov 12, 2025, 20:06 ET EirGenix ha firmado el acuerdo de licencia comercial para su segundo biosimilar de HER2, EG1206A
el producto cumple con los requisitos para una vía de desarrollo abreviada, permitiendo la exención de los ensayos comparativos de eficacia de fase III. Este acuerdo representa otro hito importante y un gran avance en los esfuerzos de EirGenix por desarrollar biosimilares. Esta alianza fortalece aún
More news about: EirGenix, Inc.
Nov 12, 2025, 20:05 ET EirGenix a signé un accord de licence commerciale pour son deuxième actif biosimilaire HER2, l'EG1206A
confirmant que le produit peut bénéficier d'une procédure de développement raccourcie, dispensant le produit des essais comparatifs d'efficacité de phase III. Cet accord marque une nouvelle étape importante et une avancée dans les efforts de développement de biosimilaires d'EirGenix. Ce partenariat renforce
More news about: EirGenix, Inc.
Nov 12, 2025, 17:35 ET LRN INVESTOR ALERT: Stride, Inc. Investors with Substantial Losses Have Opportunity to Lead the Stride Class Action Lawsuit
enrollment numbers by retaining "ghost students"; (ii) cutting staffing costs by assigning teachers' caseloads far beyond the required statutory limits; (iii) ignoring compliance requirements, including background checks and licensure laws for its employees, and ignoring federally mandated special education
More news about: Robbins Geller Rudman & Dowd LLP
Nov 12, 2025, 17:15 ET G Mining Ventures Reports Strong Q3 2025 Results
(ii) the Corporation having received the green light to advance the Gurupi project and restart the licensing process, thereby de-risking that project; (iii) exploration at Oko West and Gurupi demonstrating upside for low-risk organic growth; (iv) deliveries and works at Oko West (e.g., mining shovel,
More news about: G Mining Ventures Corp
Nov 12, 2025, 17:15 ET Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates
safety data and topline results for the phase 1b trial for our ATR-12, (ii) the abstract detailing the Phase 1/2 clinical trial for our ATR-04 program, (iii) the initiation of dosing in the Phase 1/2 clinical trial for our ATR-04 program, and (iv) statements about our clinical and preclinical programs, and
More news about: Azitra, Inc.
Nov 12, 2025, 17:08 ET i-80 Gold Reports Third Quarter 2025 Results and Project Development Progress
five projects in March 2025. These growth expenditures fall into three categories: (i) advancing permitting activities, (ii) feasibility studies, and (iii) development work at Archimedes underground. For 2025, the growth expenditures are expected to total between $40 million to $50 million that is primarily
More news about: i-80 Gold Corp
Nov 12, 2025, 17:00 ET Lument Finance Trust Reports Third Quarter 2025 Results
realized losses not otherwise included in GAAP net income (loss) and excluding (i) non-cash equity compensation, (ii) depreciation and amortization, (iii) any unrealized gains or losses or other similar non-cash items that are included in net income for that applicable reporting period, regardless of whether
More news about: Lument Finance Trust, Inc.
Nov 12, 2025, 16:59 ET Perimeter Medical Imaging AI Announces Strong Third Quarter 2025 Financial Results
material assumptions, including but not limited to (i) the accuracy of Perimeter's financial projections; (ii) obtaining positive results from trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market, and economic conditions. Further risks, uncertainties and assumptions include,
More news about: Perimeter Medical Imaging AI Inc.
Nov 12, 2025, 16:38 ET TAT Technologies Reports Third Quarter 2025 Results
and overhaul ("MRO") services for heat transfer components and OEM of heat transfer solutions through our subsidiary Limco Airepair Inc. ("Limco"); (iii) MRO services for aviation components through our subsidiary, Piedmont Aviation Component Services LLC ("Piedmont") (mainly Auxiliary Power Units ("APUs")
More news about: TAT Technologies Ltd.
Nov 12, 2025, 16:15 ET KORE Reports Third Quarter 2025 Results
measure defined as gross profit excluding certain (i) inventory adjustments that may not be indicative of ongoing operations, (ii) depreciation and (iii) amortization. Key Operational Metrics KORE reviews a number
More news about: KORE Group Holdings, Inc.
Nov 12, 2025, 16:05 ET Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update
release; (ii) Talphera's developmental product candidates may not be beneficial to patients or healthcare providers or be successfully commercialized; (iii) risks relating to Talphera's ability to obtain regulatory approvals for its developmental product candidates; (iv) risks related to the ability of Talphera
More news about: Talphera, Inc.
Nov 12, 2025, 15:37 ET El 8º Festival Internacional de Circo de China celebra una semana de espectáculos de talla mundial
los mejores actos circenses del mundo, hasta Magic Legend, el primer circo situacional a gran escala del mundo, y su versión mejorada, Magic Legend III, así como el Chimelong Show, ganador del 31º Premio TEA Thea a la Excelencia en la categoría de Espectáculo, Chimelong continúa ofreciendo funciones
More news about: Chimelong Group
Nov 12, 2025, 15:26 ET Das 8. China International Circus Festival feiert eine Woche mit Weltklasse-Vorstellungen in Hengqin Chimelong
Vorführung der besten Zirkusnummern der Welt, über Magic Legend, den ersten großen Situationszirkus der Welt, und dessen Weiterentwicklung Magic Legend III bis hin zur Chimelong Show, die mit dem 31. TEA Thea Award für herausragende Leistungen in der Kategorie Spektakel-Show ausgezeichnet wurde, bietet Chimelong
More news about: Chimelong Group
Nov 12, 2025, 15:15 ET FIEE Announces Fiscal 2025 Third Quarter Unaudited Financial Results
future financial position and results of operations of the Company, (ii) our ability to successfully implement our strategic business transformation and (iii) our long-term growth objectives and opportunities. By nature, forward-looking statements involve risks and uncertainties that
More news about: FiEE, Inc.
Nov 12, 2025, 15:10 ET Le 8e festival international du cirque de Chine célèbre une semaine de spectacles de classe mondiale à Hengqin Chimelong
meilleurs numéros de cirque au monde, jusqu'à Magic Legend, le premier cirque de situation à grande échelle au monde, et sa version améliorée Magic Legend III, en passant par le Chimelong Show, lauréat du 31e TEA Thea Award for Outstanding Achievement dans la catégorie Spectacle Show, Chimelong continue de
More news about: Chimelong Group
Nov 12, 2025, 14:01 ET O 8º Festival Internacional de Circo da China celebra uma semana de apresentações de classe mundial em Hengqin Chimelong
Gala, uma vitrine dos melhores atos de circo do mundo, até o Magic Legend, o primeiro circo situacional de grande escala do mundo, e seu Magic Legend III aprimorado, bem como o Chimelong Show, vencedor do 31º TEA Thea Award for Outstanding Achievement na categoria Spectacle Show, a Chimelong continua a
More news about: Chimelong Group